STAT+: Will MAHA survive the midterms?
As the midterm elections draw near, the MAHA movement is nearly invisible on the campaign trail and struggling to find…
Read at source →Source
STAT News
Medicine, biotech, and health policy
Health · 721 articles · page 4 of 21 · fetched about 1 hour ago
Opinion: Proposed U.S. census changes could be catastrophic for public health
“Erasing data does not erase need or harm,” writes social epidemiologist Nancy Krieger.
Read at source →
Opinion: 50 years ago, my colleagues and I pursued basic research science that became revolutionary
“Basic studies led to clinical and translational advances that no one could have predicted,” Robert Gallo writes of his…
Read at source →
AdSponsoredSiguimi
Pure chronological social — no algorithm
See who you follow, newest first. Free to join. Posts that stay visible — not buried by an algo.
Join siguimi.com →
The fall of Roe dramatically changed abortion access. This researcher used Reddit to capture how
With research on abortion access barriers, STAT Wunderkind Betsy Pleasants is defining a framework for using AI tools…
Read at source →
Trump administration investigates 9 universities for alleged visa fraud
This story has been updated. The Trump administration announced Thursday that it is investigating nine universities for…
Read at source →
STAT+: House Democrat seeks to scrap No Surprises Act’s costly arbitration process
A new proposal in Congress to scrap a surprise billing ban’s controversial arbitration system will need to to survive…
Read at source →
NIH funding uncertainty thwarts U.S. researchers
How has the NIH been spending its budget? And why are biotech investors feeling gloomy? Find out on this week's episode…
Read at source →
STAT+: AI for breast cancer risk prediction goes DTC, regulatory cloud over Utah sandbox, and AI psychosis
In this edition of STAT's Health Tech: The story of a startup taking its algorithm for breast cancer risk prediction…
Read at source →
STAT+: The fresh faces that may shake up key Senate committees ahead of midterms
Dozens of Democrats are vying for seats on the House Energy and Commerce and Ways and Means committees, with several…
Read at source →
STAT+: Roche goes beyond licensing in deal with Chinese biotech
Roche is partnering with Chinese startup Defand Therapeutics to discover new medicines.
Read at source →
FDA says its safety review of abortion pill will continue into next year
The FDA says its ongoing safety review of the nation's main abortion pill will continue into next year, a timeline that…
Read at source →
STAT+: Argenx sees unusual setback with failure of late-stage study of drug for autoimmune disease
Argenx said its blockbuster drug Vyvgart didn’t outperform placebo in a Phase 3 trial of patients with Sjögren's…
Read at source →
STAT+: Pharmalittle: We’re reading about PhRMA suing Trump, biotech frustration over tariffs, and more
PhRMA is suing the Trump administration, smaller biotech firms are frustrated over tariffs, and more of the latest…
Read at source →
STAT+: Roche inks drug discovery deal with Chinese biotech, focused on molecular glue medicines
Roche has inked a drug discovery deal with Chinese biotech Defand Therapeutics, focused on molecular glue medicines.
Read at source →
The Nobel boys club (again)
All six Nobel awardees in physiology or medicine, physics, and chemistry this year were men. Women make up 4% of…
Read at source →
STAT+: Biotech companies are struggling to navigate Trump’s new tariffs
Smaller biotech firms are trying to figure out how to win exemptions from Trump's import taxes.
Read at source →
STAT+: Dozens of Democrats vie for slots on key House health committees
Power House health committees could get a lot of new members after the midterms.
Read at source →
Opinion: How CMS plans to fix a major flaw in the 340B drug discount program
“A small, well-intended discount for safety net hospitals became a large institutional subsidy with expensive…
Read at source →
Opinion: England and other nations are on the path toward eliminating hepatitis C. Why not the U.S.?
Eliminating hepatitis C is achievable — if the U.S. seriously invests in it, experts write.
Read at source →
STAT+: Why this startup is taking its AI to predict breast cancer risk directly to patients
A startup didn't want to wait for doctors and insurers to get behind its breast-cancer risk prediction AI. So it's…
Read at source →
Breast cancer can behave differently in older women. This physician is making more tailored treatments a reality
There’s increasing evidence that older women with breast cancer could benefit from more tailored treatments. STAT…
Read at source →
A mother-daughter quest to find fellow members of an ultra-rare genetic community
“Don’t google,” the pediatric geneticist warned. It took me five years to disobey.
Read at source →
STAT+: In small trial, optogenetics restores some vision lost to retinitis pigmentosa
About half of the patients in a study regained photosensitivity in their vision, showing the promise of optogenetics.
Read at source →
Trump administration proposes $70,000 fee for popular international student work program
The Trump administration has proposed a $70,000 fee for a popular work authorization program meant to give students…
Read at source →
STAT+: PhRMA sues over Trump policy mandating lower drug prices in Medicare
The brand drug industry’s main trade group is suing the Trump administration over a pilot program tying Medicare drug…
Read at source →
STAT+: Merck suffers a setback in Europe over its new Keytruda formulation
In a setback for Merck, a Dutch court ordered a halt to the manufacturing and marketing of a subcutaneous formulation…
Read at source →
STAT+: Forbion raises $2.6 billion, its largest fundraise to date
Forbion, a prominent European venture capital firm, said it has raised $2.6 billion, its largest fundraise to date and…
Read at source →
STAT+: Why health AI pilots in Utah may be on a collision course with the FDA
In this edition of STAT's AIP Prognosis: Unresolved regulatory questions around Utah's AI sandbox, and more health AI…
Read at source →STAT+: Pharmalittle: We’re reading about WHO obesity guidelines for kids, DOJ targeting pharma, and more
The World Health Organization released its first guidelines addressing the sharp rise in obesity among children and…
Read at source →
STAT+: Justice Department targets drugmakers in new directive on combating white-collar fraud
The Justice Department issued a new directive for combating fraud that noted the agency will pursue violations of a…
Read at source →
ER visits from people born outside the U.S. dropped after ICE raids
A new study found that visits by people born outside of the U.S. to three LA emergency rooms dropped precipitously…
Read at source →
2026 Nobel Prize in chemistry awarded for ‘mirror image’ molecule research, with impact on pharmacology
Henri B. Kagan and Kenso Soai were awarded the 2026 Nobel Prize in chemistry on Wednesday for solving a mystery with…
Read at source →
STAT+: Caribou Biosciences, biotech co-founded by Jennifer Doudna, is shutting down
Caribou Biosciences is shutting down after failing to raise the money necessary to fund a late-stage clinical trial of…
Read at source →
STAT+: In Duchenne muscular dystrophy, a promising therapy is available to a fortunate few
Exon-skipping drugs present a critical test for the FDA’s goal of encouraging treatments for rare disease.
Read at source →
STAT+: Democrats plot a midterms push for MAHA voters
Key Democrats are meeting with MAHA activists and rolling out food and environmental plans to entice them.
Read at source →
Opinion: My oncologist recommended active surveillance for prostate cancer. Life insurers called it ‘untreated cancer’
“I reject the idea that a man who keeps every prostate cancer surveillance appointment has ‘untreated cancer,’” writes…
Read at source →